Comprehensive Analysis of Tissue Preservation and Recording Quality from Chronic Multielectrode Implants by Freire, Marco Aurelio M. et al.
Comprehensive Analysis of Tissue Preservation and
Recording Quality from Chronic Multielectrode Implants
Marco Aurelio M. Freire
1¤, Edgard Morya
2, Jean Faber
1,3, Jose Ronaldo Santos
1, Joanilson S. Guimaraes
1,
Nelson A. M. Lemos
1, Koichi Sameshima
2,4, Antonio Pereira
5, Sidarta Ribeiro
5, Miguel A. L.
Nicolelis
1,2,6,7,8*
1Edmond and Lily Safra International Institute of Neuroscience of Natal, Natal/RN, Brazil, 2Clinical Neurophysiology Laboratory of the Associac ¸a ˜o Alberto Santos Dumont
para Apoio a Pesquisa, Sı ´rio Libane ˆs Hospital, Sa ˜o Paulo/SP, Brazil, 3Foundation Nanosciences and Clinatec/LETI/CEA, Grenoble, France, 4Department of Radiology,
School of Medicine, University of Sa ˜o Paulo, Sa ˜o Paulo/SP, Brazil, 5Brain Institute, Federal University of Rio Grande do Norte, Natal, RN, Brazil, 6Center for
Neuroengineering, Department of Neurobiology, Duke University Medical Center, Durham, North Carolina, United States of America, 7Department of Biomedical
Engineering, Duke University, Durham, North Carolina, United States of America, 8Department of Psychological and Brain Sciences, Duke University, Durham, North
Carolina, United States of America
Abstract
Multielectrodes have been used with great success to simultaneously record the activity of neuronal populations in awake,
behaving animals. In particular, there is great promise in the use of this technique to allow the control of neuroprosthetic
devices by human patients. However, it is crucial to fully characterize the tissue response to the chronic implants in animal
models ahead of the initiation of human clinical trials. Here we evaluated the effects of unilateral multielectrode implants on
the motor cortex of rats weekly recorded for 1–6 months using several histological methods to assess metabolic markers,
inflammatory response, immediate-early gene (IEG) expression, cytoskeletal integrity and apoptotic profiles. We also
investigated the correlations between each of these features and firing rates, to estimate the impact of post-implant time
on neuronal recordings. Overall, limited neuronal loss and glial activation were observed on the implanted sites. Reactivity
to enzymatic metabolic markers and IEG expression were not significantly different between implanted and non-implanted
hemispheres. Multielectrode recordings remained viable for up to 6 months after implantation, and firing rates correlated
well to the histochemical and immunohistochemical markers. Altogether, our results indicate that chronic tungsten
multielectrode implants do not substantially alter the histological and functional integrity of target sites in the cerebral
cortex.
Citation: Freire MAM, Morya E, Faber J, Santos JR, Guimaraes JS, et al. (2011) Comprehensive Analysis of Tissue Preservation and Recording Quality from Chronic
Multielectrode Implants. PLoS ONE 6(11): e27554. doi:10.1371/journal.pone.0027554
Editor: Stephen D. Ginsberg, Nathan Kline Institute and New York University School of Medicine, United States of America
Received July 4, 2011; Accepted October 19, 2011; Published November 9, 2011
Copyright:  2011 Freire et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by Associac ¸a ˜o Alberto Santos Dumont para Apoio a ` Pesquisa, Financiadora de Estudos e Projetos (01.06.1092.00), Instituto
Nacional de Interface Ce ´rebro-Ma ´quina (704134/2009), Conselho Nacional de Desenvolvimento Cientifico e Tecnolo ´gico -Edital Universal (481506/2007-1), Pew
Latin-American Program in Biomedical Science, Defense Advanced Research Projects Agency (DARPA) contract (N66001-06-C-2019) and the National Institutes of
Dental and Craniofacial Research (NIDCR) (R01-DE011451). The content is solely the responsibility of the authors and does not necessarily represent the official
views of the NIDCR or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of
the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: nicoleli@neuro.duke.edu
¤ Current address: John B. Pierce Laboratory, Yale University, New Haven, Connecticut, United States of America
Introduction
The use of chronic multielectrodes for recording the activity of
neuronal populations in awake behaving animals [1–6] represent-
ed a great step forward in our understanding of the function of the
brain. In particular, there is great promise in the use of this
approach to allow human patients to control neuroprosthetic
devices, designed to restore function after either traumatic injury
of the central nervous system (CNS) or neurodegenerative diseases
[7–14].
An important prerequisite for any invasive brain machine
interface is to maintain a stable signal in the CNS for the longest
time possible without causing either structural, cellular or
metabolic changes capable of compromising the device’s perfor-
mance and/or resulting in tissue degeneration around the
implanted electrode [15]. For this reason, laboratories around
the world have tested different materials and designs for microwire
arrays in rodents [16,17], non-human primates [14,18,19] and
humans [20].
However, despite the increasing popularity of chronic micro-
electrode implants, relatively little is known about their long-term
effects on brain parenchyma. One of the initial events which is
better understood is activation of microglial cells after the implant
[18]. Microglial cells are very sensitive to early pathological
conditions, even if they mean only variations in extracellular ionic
concentrations [21]. These cells are fundamental for the control of
brain homeostasis and integrate the intrinsic brain defense system
[22], being immediately activated in several pathological condi-
tions such as stroke, chemical and traumatic injuries and
neurodegenerative disorders [21,23–27]. The local activation of
glial cells due to chronic electrode implants usually causes
electrode encapsulation [28], and the resulting increase in
PLoS ONE | www.plosone.org 1 November 2011 | Volume 6 | Issue 11 | e27554electrical impedance of the recording tip over time [29]. This
process presumably leads to an initial improvement of extracellular
signal’s selectivity, followed by a progressive decrease in the
number of recorded neurons, until the complete cessation of signal
[29].
Astrocytes are the major components of the encapsulating tissue
that is deposited around chronically implanted electrodes [30].
These cells are usually recruited to the site of CNS injury,
contributing to the glial scar that prevents axonal regeneration
[31]. Some authors have proposed that glial encapsulation, a
phenomenon called gliosis (i.e. a proliferation of astrocytes in CNS
injured areas) [32], insulates implanted electrodes from nearby
neurons, thereby hindering diffusion and increasing impedance
[28] or creating an inhibitory environment for neurite extension.
Understanding the complex interactions between chronic
neural implants and the cells that form the brain parenchyma is,
therefore, a crucial step in developing stable, long-term micro-
electrodes. However, many questions still remain to be clarified,
mainly regarding the effects of chronic multielectrode implants in
tissue metabolism, cell structure, brain cytoarchitecture, and cell
death, and how these potential changes relate to quality of
electrophysiological recordings over time. To address these
questions, we set out to evaluate how tungsten microelectrode
arrays implanted in the rat brain affect biological markers of tissue
metabolism, inflammatory response, immediate early gene (IEG)
expression, cytoskeletal integrity, and apoptotic cell death. To
provide a comprehensive picture of the effect of microelectrode
implants in cortical homeostasis, we also investigated the
correlation of these markers with electrophysiological signals over
time. We choose the motor cortex as target of our study because of
the relevance of this region to neuroprosthetic applications
[9,33,34].
Results
Electrophysiology
On average, 72621 (mean6SD) neuronal units per session
were chronically recorded in each animal. Recording sessions
initiated between 7 and 14 days after the implant. Figure 1
illustrates the results from a recording session in a rat implanted
during 6 months. Waveforms from 72 neuronal units recorded 1
month after array implantation are illustrated in the top left panel
of Figure 1A, with a decay of around 45% of units recorded after 3
months (middle panel) and around 85% after 6 months (right
Figure 1. Recording session in a rat implanted during six months. Waveforms of 72 sorted units recorded with a 32 microwire array
implanted in the motor cortex. Distinct neuronal units are well identified six months after implant (A). Neuronal activity varies with implantation time.
In (B) we see representative examples of neuronal ensemble firing over implantation time, showing a natural decrease of firing rates and in the
number of recorded neurons 6 months after array implantation.
doi:10.1371/journal.pone.0027554.g001
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mean6SD). The bottom panels (B) show representative samples of
neuronal ensemble firing over time, showing a decrease of firing
rates and of the number of recorded neurons 6 months after array
implantation. A summary of the total number of recorded neurons
across animals shows the existence of single-unit activity even 6
months after implantation (Figure 2).
Concerning the analysis of LFP power, although LFP can be
used to detect changes in recording quality over time, the LFP
signal is very robust and changes little over months. In fact, it is
very common that one can still record LFP from a given channel
even after no spike signal can be detected. To assess this issue we
did an analysis of power spectrum for different bands of frequency
as function of time for channels with and without spikes. We first
separated the LFP signal in standard spectral bands (0–4; 4–8; 8–
12; 12–24, and 24–60 Hz). For each rat, the band power was
divided by the total LFP power. Channels with spikes present were
compared to channels without spikes at different time points. The
results show that the relative LFP power in different bands varies
similarly in both groups of channels (Figure S1).
General histological pattern of implanted tissue
Figure 3A shows the typical pattern of electrode tracks left by
the implants in sections obtained from animals at every survival
time evaluated. The Nissl staining showed minimal cell loss in the
implanted tissue, with a preservation of neuronal bodies near the
electrode track and the absence of vacuolization. Pycnotic nuclei,
an indirect evidence of cell death, were not detected. Based solely
on the Nissl staining, the electrode arrays appear to be well
integrated and tolerated for up to 6 months after implantation.
Metabolic markers
Histochemistry for both NADPH-d and CO revealed a similar
pattern of tissue preservation (Figure 4A,B, top). Decreased
reactivity was restricted to tissue adjacent to the recording wires.
Tissue located far from the immediate vicinity of the electrodes
was not affected, showing normal reactivity, similar to the
unaffected contralateral hemisphere. This qualitative pattern was
confirmed by densitometric analysis: there was no significant
difference between regions located in the vicinity of the implanted
sites and their contralateral counterpart (Mann-Whitney test,
p.0.05) (Figure 4A,B, bottom). We noticed a non-significant trend
for a small reduction in reactivity in late survival times (Kruskal-
Wallis - Bonferroni post hoc test, p.0.05).
Pattern of neuronal labeling
NF-M, a marker of neuron integrity, revealed the presence of
morphologically normal neurons around the electrode tracks in all
survival times (Figure 5). Overall, it was possible to visualize a well-
preserved pattern of both apical and basal dendrites, and
unequivocally distinct pyramidal cell bodies in both implanted
and contralateral hemispheres. In addition, we did not detect any
difference in the pattern of cell labeling (Figure 5).
Glial activation and inflammatory response around
electrode tracks
Astrocytosis was observed around the electrode tracks, espe-
cially in later survival times, as a dense strip of cells throughout the
implanted tissue (Figure 3B). In the implantation site we identified
an astrocytic activation, as reflected by the presence of cells
displaying hypertrophic cell bodies and shorter and thicker
Figure 2. Neuronal recording average neurons/firing rate along weeks. Average number of neurons recorded over post-implantation time.
It is possible to detect good electrophysiological signal 6 months after implantation. Progression of the time of recording (in weeks) is evidenced by
the color code (first weeks: ‘hot’ colors; last weeks: ‘cold’ colors).
doi:10.1371/journal.pone.0027554.g002
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had a non-activated morphology with cells presenting non-
hypertrophic cell bodies and absence of short and thick processes.
To evaluate the presence of activated microglia, we immuno-
stained brain sections with ED-1. Glial reactivity to the
microelectrode presence in all survival times was characterized
by relatively small and localized cell activation, consisting of
macrophages/microglia located only near the implantation site
(Figure 6, top). Quantitatively, there was a small number of ED1-
positive cells close to the microelectrode (Figure 6, bottom), with
no significant difference among post-implantation times (p=0.21,
Kruskal-Wallis – Bonferroni post hoc test, corrected for the number
of comparisons). We observed an absence of ED-1-reactive cells in
a short distance away from the implanted sites and also in the
contralateral hemisphere, used as an intrinsic control (Figure 6).
Apoptotic profiles
We evaluated the presence of apoptotic profiles around
electrode tracks using the caspase-3 immunohistochemistry. We
found only a small amount of apoptotic cell death along the
electrode track across survival groups (Figure 7), but never far from
it, even in the 6-month survival group (Figure 7). In addition, since
double-labeling using caspase-3 and GFAP antibodies revealed a
strict co-localization, we propose that the observed small amount
of cell death does not correspond to neuronal death. Also, as
aforesaid, we did not detect pycnotic profiles using Nissl staining,
corroborating the relative absence of apoptotic death.
Immediate early-gene expression
The pattern of egr-1 nuclear localization was similar in both
contralateral and implanted hemispheres, with profiles varying
from intensely to weakly reactive in every region (Figure 8). This
pattern was confirmed quantitatively: there was no significant
difference between implanted and contralateral regions until 6
months of electrode implantation (Figure 8).
Relationship between histological pattern and
electrophysiological signal
In order to relate the pattern of tissue integrity to the dynamics of
electrophysiological changes, we calculated the non-parametric
Spearman correlation coefficient between firing rate and several
histological parameters, followed by a two-tailed t test for
significance (Figure 9). Correlations were separately calculated for
each group of implants and were based on median firing rates. For
rate calculation, we divided the spike count of each neuron by the
total time of recording. The resulting number allowed us to estimate
the variation of spiking activity throughout the several weeks of
recording (the absolute values are shown in Figure 2). The amount
of cells positive for Egr-1 exhibit higher correlation values during
the first weeks for all groups, with a slight decrease over time
Figure 3. General pattern of tissue preservation in implanted sites. Nissl staining reveals a minimal cell loss in the implanted tissue (arrows),
with a preservation of neurons near the electrode track and the absence of vacuolization and pycnotic profiles. In (B) we see GFAP immunostaining
revealing astrocytosis restricted to the vicinity of electrode tracks, especially in later survival times, as a dense strip of cells throughout the implanted
tissue. Notice the reactivity along electrode tracks (arrows). Astrocytes displayed a non-activated morphology with cells presenting non-hypertrophic
cell bodies and absence of short and thick processes in contralateral hemisphere (C, right side, arrowheads). In the implantation site we identified an
astrocytic activation, as reflected by the presence of cells displaying hypertrophic cell bodies and shorter and thicker processes (C, left side,
arrowheads). Scale bars: 500 mm (A, B); 100 mm (C).
doi:10.1371/journal.pone.0027554.g003
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correlations in the middle of the implant period. In addition, the
early group (1–2 months) presented a relative constant correlation
throughout the implantation period. The samecan be noticed when
we correlated firing rates with the histochemical patterns of
NADPH-d and CO. ED-1 and caspase-3 positive cells showed an
increasing correlationwithfiringratesduringthelatterimplantation
period, well-correlated with the decrease of neuronal signal.
Discussion
Here we have comprehensively characterized the general
pattern of tissue reaction and tolerance to chronic cortical
implants of tungsten microelectrode arrays, using a broad range
of histological, histochemical and immunohistochemical methods.
In addition, we established correlations between these markers and
the quality of electrophysiological signals recorded by the arrays.
We have obtained four main findings. First, the implanted tissue is
histologically, structurally, and metabolically well-preserved.
Second, electrode implantation does not affect the normal
physiology of the implanted tissue, as indicated by IEG reactivity.
Third, despite a small amount of inflammatory response and
gliosis in the implanted sites, cell death is minimal after the
multielectrode implantation. Finally, we have also observed that
electrophysiological signals were still detectable even after 6
months of implantation, in correspondence with the general
pattern of tissue integrity. There was, however, a significant decay
in the number of recorded neurons over time.
Figure 4. General pattern of histochemical markers in the implanted tissue. A small decrease is observed only in the implantation site
(arrows), with a good pattern of preservation in the subjacent tissue for both techniques (NADPH diaphorase, A; cytochrome oxidase, B), as attested
by densitometric analysis of the implanted regions when compared with their counterparts of the contralateral hemisphere (bottom of the figures).
Values referred as mean6SEM. Scale bar in A: 500 mm.
doi:10.1371/journal.pone.0027554.g004
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Biocompatibility can be defined as the capability of an
implanted prosthesis to coexist in harmony with the host tissue
without causing deleterious changes. Different materials have been
used to manufacture biocompatible multielectrode arrays so far,
such as microwire arrays and bundles [35], silicon [30] and
platinum [18], with varied impacts on tissue integrity, as measured
by the amount of reactive glia attracted to the implant site and by
the decrease in the signal-to-noise ratio (SNR) of the electrophys-
iological signal. Other factors in addition to the electrodes’
material should be considered in order to generate biocompatible
and stable implants, such as electrode shape, size, texture, tip
geometry and array configuration. Szarowski et al. (2003), in a
comparative study evaluating the tissue response to silicon
implants of different sizes, surface characteristics, and implantation
procedures, reported that glial scar formation was unaffected by
that range of variables, although distinct array geometries may
influence the initial wound response [36]. In that work, however,
the authors used only a small number of animals by group (1–2
animals), and therefore may have overlooked the inter-animal
response variability. Ward et al. (2009) assessed the effectiveness of
some commercial microelectrodes with distinct configurations
[37]. According to these authors, none of the examined arrays can
be considered superior to others, especially with respect to the
relationship between electrophysiological signal and inflammatory
response induced by the implant, although they did not quantify in
detail the glial activation levels. Biran et al. (2005) evaluated the
impact of the chronic silicon electrode arrays in the nervous tissue,
observing an elevation of glial cells numbers (both astrocytes and
microglia) accompanied by a decrease in the number of neurons in
the electrodes’ vicinity [38]. The development of this histological
pattern was accompanied by a steady decrease in the SNR,
suggesting that the glial response and cell loss impair single-unit
recordings over time.
In the present work we observed a small degree of tissue
alteration induced by the presence of tungsten microelectrode
arrays. Tungsten is a good choice of material for chronic implants
since it is a stable and inert metal, and has been successfully used
to simultaneously record neuronal populations for several months
and even years [3,19,35,39]. In agreement with this, we detected
small metabolic loss restricted to the sites of electrode implanta-
tion, a well-preserved structural organization, as revealed by the
normal morphology of pyramidal cells, and a normal tissue
physiology, indicated by unaltered levels of Egr-1 expression,
directly involved with synaptic plasticity [40,41]. In addition,
neuronal death was not more prominent in the implanted sites.
Altogether, these results indicate that Teflon-coated tungsten
microwire arrays are well-tolerated by the nervous tissue. Some
other factors that could explain these findings are the flexibility of
the electrode’s shaft and the shape of the tip. Tungsten microwires
are sufficiently rigid to allow tissue penetration, and yet are flexible
enough to prevent shear and tear due to their relative movement
with respect to the brain. Biocompatibility is also aided by the use
of blunt electrode tips, instead of electrodes with sharp tips that
easily damage the tissue when movement occurs. The combination
of these features likely explains why multielectrode arrays made of
blunt tungsten wires may be chronically implanted for several
months and still be sturdily tolerated by the nervous tissue, without
causing widely deleterious effects.
In our study we observed the decay of the neuronal activity
during implantation time. Based in the well-preserved pattern of
neuronal morphology and Egr-1 expression, we believe that the
progressive drop of neuronal activity is associated more directly to
the glial encapsulation of the electrode rather than a loss of tissue
Figure 5. Pattern of neuronal labeling around electrode tracks.
Using immunohistochemistry for NF-M we observed normal neuronal
morphology around the electrode tracks (arrow) in all survival time
groups it is possible to visualize a well-preserved pattern of both apical
and some basal dendrites, as well as distinct pyramidal cell bodies
(enlargements). Scale bars: 500 mm; 100 mm (enlargements).
doi:10.1371/journal.pone.0027554.g005
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reports (see [42] for a review). Further studies, mainly employing
electronic microscopy to evaluate the tissue attached to the
electrode after withdrawal from the parenchyma can help to
clarify this issue.
Specifically concerning Egr-1 expression, since we did not apply
extra sensory stimulation to the animals other than the normal
amount of stimulation of being awake in a cage, we did not assess
Egr-1 response to stimulation. Instead, we evaluated baseline levels
of its expression, which tend to be high [43,44] and proportional
to neural activity [43,74]. So, the fact that Egr-1 labeling was
constant over time indicates that the decaying firing rates detected
by the multielectrode implants in our study does not reflect a
physiological decay, but rather an effect of gliosis.
Electrode implants and inflammatory response
The inflammatory response is a very important physiological
mechanism to safeguard tissue against the action of aggressive
agents or mechanical/chemical injuries. Accordingly, no matter
the array configuration and the material, the inflammatory
response is always present in chronic implants and consequently
electrodes tend to lose their effectiveness over time. The
induction of tissue inflammation by chronic neural implants
cannot be completely avoided because even a tiny mechanic
lesion provokes alterations in the tissue milieu and a consequent
recruitment of inflammatory cells and the glial activation [27].
Since it seems obvious that some inflammatory response will
occur, especially during the process of electrode implantation,
one of the main goals would be to ensure that the tissue reaction
to the foreign body can be maintained at a tolerable level.
Bjornsson et al. (2006) reported extensive short-term effects of
electrode insertion, including cell death (both neuronal and glial),
severed neuronal processes and blood vessels, mechanical tissue
compression, and collection of debris resulting from cell death
[45]. A prolonged and exacerbated inflammatory response
mediated by pro-inflammatory cytokines such as tumor necrosis
factor alpha (TNF-a), interleukin 1 beta (IL-1b), and nitric oxide
(NO) can be highly harmful to the nervous tissue [46–48]. For
instance, even when the foreign body cannot be degraded, as in
the case with implanted electrodes whose material composition is
resistant to enzymatic dissolution, yet the inflammatory reaction
contributes to recording failure, by releasing necrotic substances
into the immediate vicinity [49] and contributing to cell death
around the electrode. However, the deleterious effects of
inflammation can be modulated with pharmacological approach-
es, such as the administration of the N-methyl-d-aspartate
receptor antagonist MK-801 and minocycline, a synthetic
analogue of tetracycline [50–53], which can easily cross the
blood-brain barrier [54,55]. These drugs could act directly in the
implantation site in order to control the inflammatory response,
helping to sustain an effective electrophysiological record for a
longer period of time.
It is important to keep in mind regarding tissue response to
microelectrode implants that although microglial cells seem to
have the same role as resident macrophages in the nervous system
of all mammalian species, other functions could be more species
specific [56]. In this context, it is interesting to have in perspective
the action of these cells in humans submitted to a chronic
multielectrode implant. For example, in rats, reactive microglia
produces a higher amount of nitric oxide (NO) than in humans
[56]. This interspecies difference could explain, for instance, why
chronic recordings in non-human primates last longer than in rats.
Although we cannot generalize the results we found in rats, our
findings are promising, given the lesser reactivity of human
microglial cells as compared to the rat’s [56]. The use of anti-
inflammatory substances could help maintain the implant’s
functionality for a longer time by the selective blockade of
microglial activity, since reactive oxygen species produced by
microglia are widely harmful to the nervous tissue [47].
Conclusion
Our results have particular relevance for the future develop-
ment of cortical neuroprosthetic devices [6,9,11,14,57]. The main
long-term goal of this research line is to contribute with
information that may in the future allow neurological patients to
use spared brain tissue to compensate for the loss of function,
based on the correlation between neuronal activity and specific
behaviors [58]. To this end, more studies need to be carried out,
testing for instance alternative electrode array configurations, in
order to provide a stable and biocompatible interface for humans
patients suffering degenerative diseases, such as Parkinson’s,
Alzheimer’s, cerebral palsy, amyotrophic lateral sclerosis, stroke
and spinal cord injury [33,59–62]. Further studies employing the
use of specific substances to control the inflammatory process
triggered mainly during the electrode implant can also contribute
to increase the effectiveness of the implant.
Materials and Methods
Multielectrode implants
Twenty-four adult male Wistar rats (300–350 g) were used in
this study. All experimental procedures were strictly in accordance
with the National Institute of Health Guide for the Care and Use
of Laboratory Animals (NIH Publications No. 80–23) and were
approved by the Edmond and Lily Safra International Institute of
Neuroscience of Natal Committee for Ethics in Animal Experi-
mentation (permit ID # 04/2009).
Surgeries for multielectrode implantation were performed in
rats deeply anesthetized with 100 mg/kg of ketamine chlorhydrate
and 5 mg/kg xylazine chlorhydrate, as described in detail
elsewhere [29]. Briefly, rats were placed in a stereotaxic head
holder, and a small craniotomy was made over the implant target
area, the primary motor cortex, using the following coordinates (in
millimeters relative to bregma): 1.0–3.0, anteroposterior (AP); 2.0–
3.0, mediolateral (ML); 1.8–2.0, dorsoventral (DV) [63]. Each
animal was slowly implanted with multielectrode arrays (468 with
500 mm spacing) made of 32 Teflon-coated tungsten electrodes
(35-mm microwire diameter, 1.5 MOhm at 1.0 KHz), attached to
an Omnetics connector (Omnetics Connector Corp., USA)
(Figure 10). All the implantation procedures were guided by
multiunit recordings, though without online sorting, for a better
dorsoventral localization. Although this procedure prolongs the
surgery, it ensures best results for chronic spike recordings. In our
Figure 6. General pattern of inflammatory response. We found a relatively small but persistent and localized microglial activation consisting of
macrophages/microglia located only nearly implantation site (A, arrow). Notice the similar morphological aspect of activated microglia in all groups
(B). The quantitative analysis revealed a non-significant difference among groups, although there is a trend to a high number of activated microglial
cells in the 6 months group (C). Quantitative analysis reveals that microglial activation is restricted to the vicinity of implants (D). Values expressed as
mean6SEM. Scale bar: 500 mm; 100 mm (enlargements).
doi:10.1371/journal.pone.0027554.g006
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stayed above the cranium, outside the tissue, in order to prevent
any alteration in the cortical mantle (Figure S2).
After 1 week to surgical recovery, animals underwent weekly
sessions of electrophysiological recordings. Four survival time
groups were formed, according to the time of killing: 1–2, 3, 4–5
and $6 months after implant.
Electrophysiological recordings
A 32-channel multi-neuron acquisition processor (MAP, Plexon
Inc., USA) was used for digital spike waveform discrimination and
storage. Single-unit recording sessions lasted for at least 30 minutes
in a weekly basis, while the rats moved freely in their cages
(Figure 10). Online spike sorting was conducted with the help of
the SortClient 2002 software (Plexon Inc., USA). All the action
Figure 7. Relationship between cell death and astrocytosis in implanted tissue. We found a small amount of apoptotic cell death across
groups located throughout the electrode tracks (arrows) even in the later group, as revealed by immunofluorescence. In addition we can see the
astrocytes located around the electrode tracks in all time points. Scale bar: 500 mm.
doi:10.1371/journal.pone.0027554.g007
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sorted online by only one investigator and validated by offline
analysis (Offline Sorter 2.3, Plexon Inc., USA) according to the
following cumulative criteria: a) voltage thresholds .3 standard
deviations of amplitude distributions; b) signal-to-noise ratio .2.5
(as verified on the oscilloscope screen); c) less than 0.5% of inter-
spike intervals (ISI) smaller than 1.0 ms; d) stereotypy of waveform
shapes, as determined by a waveform template algorithm and
principal component analysis. Local field potentials (LFP) were
simultaneously recorded from the wires and pre-amplified (500x),
filtered (0.3–400 Hz), and digitized at 500 Hz using a Digital
Acquisition board (National Instruments, USA) and a MAP box
(Plexon Inc., USA) (Figure 10).
Sort Client, the main user interface in the recording software
from Plexon Inc. (RASPUTIN software), allows spike sorting
through two basic tasks: detection and classification. A voltage-
threshold trigger is one of the simplest ways to detect spikes and
sorting them in real time according to their shape. The detection
process can be easily applied within a brief period of time for all 32
channels, and the classification of neurons was made individually,
channel by channel. Usually large amplitude waveforms were
quite different from those closer to threshold, allowing an
unambiguous discerning of distinct neurons (Figure 11).
We compared sorting performed both online and offline for
consistency. The electrophysiological sorting criteria were updated
in every recording session, but we used the manual online sorting
capability of the SortClient software instead of the automated
online sorting. The selection of individual neurons in all recording
sessions followed the same criteria over time, as defined above. In
this way, we could follow the amount of clearly distinct individual
neurons, despite variations in the background noise.
Perfusion
At the end of pre-specified survival times, animals were deeply
anesthetized with 5% isoflurane and overdosed with sodium
thiopental (90 mg/kg). Animals were then perfused intracardially
with 0.9% heparinized saline followed by 4% paraformaldehyde in
0.1 M phosphate buffer (PB), pH 7.4. Next, the brains were
removed from the skull and immersed in 20% sucrose in 0.1 M
phosphate buffer saline (PBS) for 12 h. The tissue was then frozen in
a embedding medium (Tissue Tek, Sakura Finetek, Japan) and
sectioned frontally at 20 mm in a cryostat (Carl Zeiss Micron HM
550, Germany). The sections were mounted on electrically charged
glasses (Super Frost Plus – VWR International, USA) and submitted
to histological, histochemical and immunohistochemical procedures.
Basic histology and histochemistry
To evaluate tissue reactivity around the electrode tracks we
used nicotinamide adenine dinucleotide phosphate-diaphorase
(NADPH-d) and cytochrome oxidase (CO) histochemistries, both
outstanding markers of cortical modules and layers [64,65]. In
Figure 8. Immediate-early gene activation across implanted sites. We identified a normal pattern of labeling of Egr-1 protein, with a pattern
of nuclear localization similar in contralateral and implanted hemispheres (A), with profiles varying from intensely to weakly reactive (B). There was no
significant difference between implanted and contralateral regions until 6 months of electrode implantation (C). Quantitative analysis reveals that
number of Egr-1-active cells does not differ significantly when regions near and far from the implant are compared (D). Values expressed as
mean6SEM. Scale bars: 500 mm; 100 mm (enlargements).
doi:10.1371/journal.pone.0027554.g008
Figure 9. Correlation between different markers of tissue integrity and firing rates. In all groups histological markers exhibit higher
correlations with firing rates during the initial post-implantation weeks, with a gentle decrease over time. The later group (up to 6 months) presented
an increased correlation at the middle of implant period, mainly concerning histochemistry techniques. In addition, the early group (1–2 months)
presented a relative constant correlation throughout the implantation period.
doi:10.1371/journal.pone.0027554.g009
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0.1 M Tris buffer, pH 8.0 and incubated in a solution containing
0.6% malic acid, 0.03% nitroblue tetrazolium, 1% dimethylsulf-
oxide, 0.03% manganese chloride, 0.5% b-NADP and 1.5%
Triton X-100 in 0.1 M Tris buffer, pH 8.0 [66]. The histochem-
ical reaction was monitored every 30 min to avoid overstaining
and was interrupted by rinsing sections in 0.1 M PB. We revealed
CO activity by incubating sections in a solution containing 0.05%
diaminobenzidine (DAB), 0.03% cytochrome c and 0.02% catalase
in 0.1 M PB [67]. Similar to NADPH-d, the CO histochemical
reaction was monitored every 30 minutes and was terminated by
washing sections in 0.1 M PB.
Alternate sections were stained with cresyl violet (Nissl method)
in order to identify the location of the electrode tracks. Before
visualization, all sections were dehydrated and coverslipped with
Entellan (Merck, Germany).
Figure 10. General aspect of multielectrode array and electrophysiological signal recording. A 32 channel microelectrode array (A). In (B)
we see a recording session after a 1-month of implantation procedure, with the headstage connected to the rat. (C) shows examples of sorted
waveforms using the Real-time Acquisition System Programs for Unit Timing in Neuroscience (RASPUTIN - Plexon Neurotechnology Research
Systems) after one (top), three (middle) and six months of implantation (bottom). Samples of channels in which at least three clearly well-isolated
single neurons are identified and recorded in real-time during the exploratory activity of the animal.
doi:10.1371/journal.pone.0027554.g010
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In order to evaluate tissue integrity, we performed a series of
immunohistochemical procedures. We labeled activated microglia
with ED-1 antibody (1:500; Serotec, UK) [68]. Astrocytes were
labeled with an antibody against the glial fibrillary acid protein
(GFAP; 1:500; Sigma Company, USA) [69]. IEG activation was
measured with immunohistochemistry against egr-1 (1:100; Santa
Cruz Biotechnology, USA), a well-known marker of calcium-
dependent neuronal activity [70]. Neurofilament M (NF-M), a
structural constituent of neuronal cytoskeleton, was revealed using
a monoclonal NF-M antibody (1:100; Santa Cruz Biotechnology,
USA) [71]. Apoptotic cells were labeled using caspase-3 antibody
(1:250; Promega, USA), a very sensible marker of these cells in the
brain [72]. In brief, the sections were washed during 20 minutes in
phosphate buffer saline-Tween (PBS-T) and incubated in a
blocking buffer solution (0.5% fresh skim milk and 0.3% Triton
X-100 in 0.1 M PBS) for 30 minutes to block non-specific binding.
Afterward, sections were incubated overnight in primary antibody
(diluted in blocking buffer) at 18uC, washed in PBS-T by 20
minutes, incubated with a biotinylated secondary antibody (1:200,
Vector Labs, USA; diluted in blocking buffer) for 2 h, washed
during 20 minutes in PBS-T, and then incubated in avidin-biotin-
peroxidase solution (Vectastain Standard ABC kit, Vector Labs,
USA) for 2 h. Slides were then placed in a solution containing
0.03% 3,39 diaminobenzidine (DAB) (Sigma Company, USA) and
0.001% hydrogen peroxide in 0.1 M PB, dehydrated and
coverslipped with Entellan (Merck). In order to certify the
specificity of the labeling the primary antibodies were replaced
by blocking buffer in some test sections.
To determine which cells were apoptotic, animals from every
group had some sections immunohistochemically stained using
fluorescent labels. Briefly, sections were washed during 1 h in
0.5% Triton X-100 in 0.1 M PB and pre-incubated in blocking
buffer solution during 30 minutes. Thereafter, the sections were
incubated overnight with primary antibodies (NF-M, GFAP and
caspase-3) at 18uC. Sections were then washed in 0.1 M PB (3x, 5
minutes each) and incubated in a mixture of Alexa Fluor 488-
conjugated horse anti-mouse and Alexa Fluor 594-conjugated goat
anti-rabbit overnight (1:500 in 0.1 M PBS, Invitrogen, USA).
Finally, the sections were mounted using Vectashield mounting
medium for fluorescence (DAPI/Antifade solution) (Vector Labs,
USA) and sealed with Entellan (Merck). The following combina-
tions were evaluated: NF-M with caspase-3 and GFAP with
caspase-3.
Qualitative and quantitative analysis
NADPH-d and CO reactivities were assessed by optical
densitometry with the Image J software (http://rsb.info.nih.gov/
Figure 11. Multielectrode recording. All the electrode implants were guided by multiunit recordings, though without online sorting (detection
by threshold or classification) (A). Multiunit activity in a single channel. The default threshold for the highlighted channel allowed the detectiono f
multiple spikes and three units could have been easily isolated (A, left side). After adequate thresholding it was possible to isolate distinct units in the
channel (defined by different colors) (B). Large amplitude waveforms stand out from those closer to threshold (C). PCA analysis was used to single out
three different units in this channel (D, right side).
doi:10.1371/journal.pone.0027554.g011
Biocompatibility of Multielectrode Implants
PLoS ONE | www.plosone.org 13 November 2011 | Volume 6 | Issue 11 | e27554ij/). Measurements were obtained inside a 0.02 mm
2 square
window positioned across electrode tracks. To minimize the effects
of within-group variability, we adopted a normalized scale based
on the reactivity of the underlying white matter (averaged over
measurements of 10 different sites using the same window). For
each animal, a contrast index was calculated according to the
equation: C=(G–W)/(G+W) [73], in which G is the average
optical density (OD) of cortical tissue around the electrode tracks,
and W is the OD of the underlying white matter. Reactivity values
were obtained for each implanted region and compared with their
contralateral counterpart. Statistical significance was assessed
using non-parametric Mann-Whitney test and Bonferroni post hoc
test with an alpha level of 0.05.
To quantify the immunohistochemical data, we counted the
total number of cells labeled by egr-1, ED-1 and caspase-3 in the
region around electrode tracks in the four survival time groups (1–
2, 3, 4–5 and $6 months of implant) using the Neurolucida system
(MBF Bioscience Inc., USA). For every marker, we quantified 3
sections per animal, sampling tissue from regions where the
electrode tracks could be unequivocally observed (n=4–5 animals
by group). The cell density (cells/10,000 mm
2) was estimated using
an automatic grid from the Neurolucida program. The contours of
positive astrocytes and NF-M labeled cells were qualitatively
evaluated across groups in order to characterize astrocytic
activation and general morphology, respectively. The hemisphere
contralateral to the implant was adopted as an intrinsic control in
all animals. Average values for all measurements were assessed
with non-parametric Kruskal-Wallis test and Bonferroni post hoc
test. The criterion for statistical significance was preset at an alpha
level of 0.05. Average values are expressed as mean6standard
error of mean (SEM).
To obtain digital images we used a CX9000 camera (MBF
Bioscience Inc., USA), attached to a light field Nikon Eclipse 80i
optical microscope (Nikon, Japan - 10x and 20x objectives).
Co-localization of NF-M and GFAP with caspase-3
Double-labeled sections for NF-M with caspase-3 and GFAP
with caspase-3 were evaluated with the aid of a Nikon Eclipse 80i
microscope (Nikon, Japan) equipped with a mercury fluorescence
light source. Images were captured with the abovementioned
digital camera at a single focal depth in the superficial portion of
the section, to which both primary antibodies had penetrated. The
images (20 and 40x objectives) were captured for each combina-
tion of antibodies from different sections processed. A composite
image was obtained by superimposing the two images captured for
each fluorophore using Image J software.
Electrophysiological signal
We evaluated the quality of the electrophysiological signal by
comparing the total number of neuronal units observed in the first
and last recording sessions. We also characterized the decay of
recorded units over time, thus assessing the quality of signal
throughout all weeks of recording.
Correlation between electrophysiological variables and
histological features
In order to measure the relationship between the pattern of
electrophysiological records throughout implantation and the
tissue integrity, we calculated the non-parametric Spearman
correlation coefficient of (or between) neuronal average firing rate
(or average spiking counting), taken for each week, and distinct
histochemical/immunohistochemical techniques, followed by a
two-tailed t test for significance (with p,0.05) using Matlab 2008
software (The MathWorks Inc., USA).
Supporting Information
Figure S1 Relative LFP power across distinct frequency
bands varies little over time, and does not differ
between channels with or without spike signals. The
top panels depict raw LFP signals recorded at different time points
(weeks), obtained from channels with or without spike signals (red
and blue lines, respectively). The remaining panels show the
temporal evolution of the relative LFP power within standard
spectral bands, for the two groups of channels described above.
(TIF)
Figure S2 Multielectrode implantation. Figure showing
the procedure of multielectrode implantation. In our surgeries the
connector of the electrode array always stayed above the cranium,
in order to prevent any alteration in the cortical mantle (zoomed at
the right side).
(TIF)
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